DBV Technologies (DBVT) Change in Working Capital (2016 - 2019)
DBV Technologies (DBVT) reported Change in Working Capital of $2.9 million for Q3 2019, down 13.23% year-over-year from $3.4 million in Q3 2018, and down 32.51% on a QoQ basis from $4.3 million in Q4 2018.
DBV Technologies (DBVT) has 4 years of Change in Working Capital data on file, last reported at $2.9 million in Q3 2019.
- Quarterly Change in Working Capital fell 13.23% year-over-year to $2.9 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $2.9 million (down 13.23% YoY) and the FY2019 annual result came in at -$3.4 million, down 1012.06% from the prior year.
- Change in Working Capital declined to $2.9 million in Q3 2019 per DBVT's latest filing, from $4.3 million in the prior quarter.
- Across five years, Change in Working Capital topped out at $4.3 million in Q4 2018 and bottomed at $2.5 million in Q4 2016.
- The 4-year median for Change in Working Capital is $2.9 million (2019), against an average of $3.2 million.
- The widest annual swing landed in 2018, when Change in Working Capital surged 54.84%; it then slipped 13.23% in 2019.
- Tracing DBVT's Change in Working Capital over 4 years: stood at $2.5 million in 2016, then gained by 12.18% to $2.8 million in 2017, then soared by 54.84% to $4.3 million in 2018, then sank by 32.51% to $2.9 million in 2019.
- Per Business Quant, the three latest DBVT Change in Working Capital figures stand at $2.9 million (Q3 2019), $4.3 million (Q4 2018), and $3.4 million (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 2.91 Mn |
| Sep 30, 2019 | 2.91 Mn |
| Dec 31, 2018 | 4.31 Mn |
| Dec 31, 2018 | 4.31 Mn |
| Sep 30, 2018 | 3.35 Mn |
| Sep 30, 2018 | 3.35 Mn |
| Dec 31, 2017 | 2.78 Mn |
| Dec 31, 2017 | 2.78 Mn |
| Dec 31, 2016 | 2.48 Mn |
| Dec 31, 2016 | 2.48 Mn |